review Open AccessTop 1% cited
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Nature reviews. Immunology · 2020 · Vol. 20(11) · pp. 651–668
Alex D. Waldman✉(National Institutes of Health)Jill M. Fritz(National Institutes of Health)Michael J. Lenardo(National Institutes of Health)
Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer immunotherapyImmunotherapyClinical trialCancerChimeric antigen receptorTumor immunologyBench to bedsideMedicineImmune checkpointImmunology
MeSH terms
Immune Checkpoint InhibitorsAnimalsClinical Trials as TopicHumansImmunotherapyNeoplasmsT-LymphocytesImmunotherapy, AdoptiveCancer Vaccines
Funding
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Emory University
- National Institutes of Health
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research
Citations
4,024
FWCI
189.70
field-weighted impact
References
303
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Frontiers in Pharmacology · 2022 · 410 citations
References
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
The EMBO Journal · 1992 · 3,162 citations
The PD‐1 pathway in tolerance and autoimmunity
Immunological Reviews · 2010 · 2,263 citations
Molecular and cellular insights into T cell exhaustion
Nature reviews. Immunology · 2015 · 4,348 citations
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology · 2014 · 1,480 citations
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Journal of Clinical Oncology · 2010 · 2,913 citations
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Leukemia · 2004 · 811 citations
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Nature Medicine · 2002 · 4,970 citations
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
Immunity · 2007 · 1,731 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.